Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

422
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
422
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

916
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
916
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

417
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
417
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

419
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
419
Oogenesis02:07

Oogenesis

69.0K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
69.0K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Discovery of Novel Small-Molecule Inhibitors of PD-1/PD-L1 Interaction via Structural Simplification Strategy.

Molecules (Basel, Switzerland)·2021
Same author

Case Report: Pink Urine Syndrome Following Exposure to Propofol: A Rare, Impressive but Benign Complication.

Frontiers in pharmacology·2021
Same author

TMT-based quantitative proteomic analysis of the effects of Pseudomonas syringae pv. tabaci (Pst) infection on photosynthetic function and the response of the MAPK signaling pathway in tobacco leaves.

Plant physiology and biochemistry : PPB·2021
Same author

Peritumoral Microgel Reservoir for Long-Term Light-Controlled Triple-Synergistic Treatment of Osteosarcoma with Single Ultra-Low Dose.

Small (Weinheim an der Bergstrasse, Germany)·2021
Same author

Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF-κB signalling pathway.

Journal of cellular and molecular medicine·2021
Same author

PSSP-MVIRT: peptide secondary structure prediction based on a multi-view deep learning architecture.

Briefings in bioinformatics·2021

関連する実験動画

Updated: Jan 15, 2026

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis
10:32

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis

Published on: June 10, 2020

4.5K

オルリスタットはクラミジア・トラコマチスの発達サイクルを阻害することで、その発達を妨げる

Jingpin Gao1, Mingxin Jiang1, Jianlin Chen1

  • 1Reproductive Medicine Center, Department of gynecology and obstetrics, The second Xiangya Hospital, Central South University, Changsha, Hunan, China.

Microbial pathogenesis
|January 13, 2026
PubMed
まとめ

減量薬であるオルリスタットは、一般的な細菌性STIであるクラミジア・トラコマチスの発達サイクルを阻害する。この発見は、クラミジア感染症の標準的な抗生物質が効かない場合の治療のための潜在的な新しい戦略を提供する。

キーワード:
クラミジア・トラコマチスオルリスタット脂質代謝

さらに関連する動画

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

13.3K
Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

13.2K

関連する実験動画

Last Updated: Jan 15, 2026

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis
10:32

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis

Published on: June 10, 2020

4.5K
A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

13.3K
Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

13.2K

科学分野:

  • 細菌学
  • 微生物病原性
  • 創薬

背景:

  • クラミジア・トラコマチスは、泌尿生殖器感染症を引き起こす一般的な性感染細菌である。
  • 感染は、無症候性の進行により、慢性炎症や線維症につながる可能性がある。
  • アジスロマイシンやドキシサイクリンなどの現在の治療法は、記録された治療上の失敗に直面している。

研究 の 目的:

  • オルリスタットがクラミジア・トラコマチスの発達サイクルを阻害する可能性を調査すること。
  • invitroおよびinvivoでのクラミジア感染に対するオルリスタットの効果を評価すること。

主な方法:

  • invitroおよびinvivoモデルを使用して、クラミジア・トラコマチスに対するオルリスタットの効果を評価した。
  • 感染中の遺伝子発現への影響を理解するために、トランスクリプトーム解析が用いられた。

主要な成果:

  • オルリスタットはクラミジア感染の初期段階を阻害することが示された。
  • この薬は、網様体から小体への網様体の複製と分化を妨げた。
  • トランスクリプトームデータは、クラミジアの中後期発達に重要な遺伝子のダウンレギュレーションを示した。

結論:

  • オルリスタットはクラミジア・トラコマチスの発達サイクルを破壊する。
  • この発見は、オルリスタットをクラミジア感染症、特に従来の抗生物質に耐性のある感染症に対する潜在的な治療薬として示唆している。
  • オルリスタットがクラミジア・トラコマチスに対して作用するメカニズムを完全に解明するには、さらなる研究が必要である。